New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
The transaction marks a clear portfolio reshuffle for Indoco
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
Company to highlight science-backed actives, nature-powered ingredients, and its new “Natural by Barentz” private label platform in Barcelona
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
